Tambong, Marilou .

HRN: 27-85-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFTAZIDIME 1GM (VIAL)
09/25/2025
10/02/2025
IV
1 Gm
Q 6h
DM Foot, Right
Checking Initial Appropriateness 
09/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/25/2025
10/02/2025
IV
600mg
Q 6h
DM Foot, Right
Checking Initial Appropriateness 
10/02/2025
CLINDAMYCIN 300MG (CAP)
10/02/2025
10/09/2025
PO
300mg
TID
DM Foot
Waiting Final Action 
10/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/10/2025
10/12/2025
IV
600mg
Q8H
S/P BKA, Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: